tiprankstipranks
Trending News
More News >
Clover Biopharmaceuticals Ltd. (HK:2197)
:2197
Hong Kong Market

Clover Biopharmaceuticals Ltd. (2197) Income Statement

Compare
0 Followers

Clover Biopharmaceuticals Ltd. Income Statement

Last quarter (Q2 2025), Clover Biopharmaceuticals Ltd.'s total revenue was ¥3.25M, an increase of 1166.15% from the same quarter last year. In Q2, Clover Biopharmaceuticals Ltd.'s net income was ¥-101.27M. See Clover Biopharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 38.42M¥ 39.26M¥ 0.00¥ 0.00¥ 0.00
Gross Profit
¥ -672.94M¥ 24.24M¥ -475.64M¥ -66.27M¥ 0.00
Operating Expenses
¥ 278.26M¥ 896.33M¥ 1.88B¥ 2.17B¥ 304.65M
Depreciation and Amortization
¥ 38.30M¥ 74.74M¥ 28.98M¥ 12.29M¥ 1.57M
EBITDA
¥ -916.54M¥ -45.07M¥ -2.37B¥ -2.23B¥ -335.04M
Operating Income
¥ -951.21M¥ -2.58B¥ -2.35B¥ -2.24B¥ -304.65M
Other Income/Expenses
¥ 47.78M¥ 2.44B¥ -100.70M¥ -3.78B¥ -608.25M
Pretax Income
¥ -903.43M¥ -138.54M¥ -2.45B¥ -6.02B¥ -912.90M
Net Income
¥ -903.43M¥ -138.54M¥ -2.45B¥ -6.02B¥ -915.87M
Per Share Metrics
Basic EPS
¥ -0.72¥ -0.11¥ -2.22¥ -5.37¥ -0.79
Diluted EPS
¥ -0.72¥ -0.11¥ -2.22¥ -5.36¥ -0.79
Weighted Average Shares Outstanding
1.25B 1.24B 1.10B 1.12B 1.16B
Weighted Average Shares Outstanding (Diluted)
1.25B 1.24B 1.10B 1.12B 1.16B
Currency in CNY

Clover Biopharmaceuticals Ltd. Earnings and Revenue History